Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group. [electronic resource]
Producer: 20000905Description: S29-34 p. digitalISSN:- 0954-6111
- Administration, Inhalation
- Adolescent
- Adult
- Aerosol Propellants -- adverse effects
- Aged
- Aged, 80 and over
- Androstadienes -- administration & dosage
- Anti-Asthmatic Agents -- administration & dosage
- Asthma -- drug therapy
- Chlorofluorocarbons -- adverse effects
- Double-Blind Method
- Female
- Fluticasone
- Forced Expiratory Volume -- physiology
- Humans
- Hydrocarbons, Fluorinated -- adverse effects
- Hydrocortisone -- blood
- Male
- Middle Aged
- Peak Expiratory Flow Rate -- physiology
- Therapeutic Equivalency
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.